What is Coeptis Therapeutics Inc?
, together with its subsidiaries, operates as a biopharmaceutical company.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, together with its subsidiaries, operates as a biopharmaceutical company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 68.21M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.